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Alcohol is a teratogen that induces a variety of abnormalities
including brain and facial defects [Jones, K. & Smith, D. (1973)
Lancet 2, 999-1001], with the exact nature of the deficit depending
on the time and magnitude of the dose of ethanol to which
developing fetuses are exposed. In addition to abnormal facial
structures, ethanol-treated embryos exhibit a highly characteristic
pattern of cell death. Dying cells are observed in the premigratory
and migratory neural crest cells that normally populate most facial
structures. The observation that blocking Sonic hedgehog (Shh)
signaling results in similar craniofacial abnormalities prompted us
to examine whether there was a link between this aspect of fetal
alcohol syndrome and loss of Shh. We demonstrate that adminis-
tration of ethanol to chick embryos results in a dramatic loss of Shh,
as well as a loss of transcripts involved in Shh signaling pathways.
In contrast, other signaling molecules examined do not demon-
strate such dramatic changes. Furthermore, we demonstrate that
both the ethanol-induced cranial neural crest cell death and the
associated craniofacial growth defect can be rescued by application
of Shh. These data suggest that craniofacial anomalies resulting
from fetal alcohol exposure are caused at least partially by loss of
Shh and subsequent neural crest cell death.
The secreted protein Sonic hedgehog (Shh) is essential formultiple events during embryogenesis, including proper
craniofacial development (1–4). Of the vertebrate homologues
of the Drosophilia segment polarity gene Hedgehog, Shh has the
widest expression pattern in the developing head, including the
presence of transcripts in the developing branchial arches during
the time of neural crest migration (5). SHH mutations in both
mice and humans cause significant defects in head development,
including distinctive facial and brain abnormalities (3, 4). Anal-
ogously, inhibition of Shh-signaling during facial development
causes neural crest cell death and a subsequent reduction in head
size (1).
There are several intriguing similarities in the craniofacial
phenotypes observed in embryos treated with ethanol and those
treated with antibodies that block Shh signaling. Both treatments
result in a reduction in head size and selective apoptosis of
cranial neural crest cells. The neural crest cell death observed
after blocking Shh signaling in the chick (1) is similar to that
observed after ethanol exposure in a number of species including
mouse, chick, and quail, both in vivo and in vitro (6–10).
However, the mechanisms by which alcohol affects selective
target tissues remain unknown.
In this study, we investigate the impact of embryonic exposure
to ethanol on Shh signaling during the critical period of early
cranial neural crest migration. After ethanol exposure, we noted
a reduction in the mRNA levels of Shh both by in situ hybrid-
ization and reverse transcriptase (RT)-PCR, as well as a reduc-
tion in the mRNA for a number of genes in the Shh signaling
cascade. We further demonstrate that cranial neural crest cells
can be rescued from ethanol-induced cell death, and that the
associated decrease in size of the frontonasal mass can be
prevented by application of exogenous Shh. We have thus
identified a molecular deficit associated with embryonic expo-
sure to ethanol that in turn represents a link to the etiology of
craniofacial defects.
Materials and Methods
Embryos. Chicken eggs were obtained from local sources. Eggs
were incubated at 37°C with constant humidity. In preliminary
experiments, unopened eggs were injected with 200 l of a
solution of 10% ethanol in Ringer’s solution, or with Ringer’s
solution alone, at 26 h of incubation. This procedure has been
previously demonstrated to result in craniofacial abnormalities
(6). We then modified this procedure, such that eggs were
opened at stage 9–10, and 20 l of a 1% ethanol solution (in
Ringers) was placed between the vitelline membrane and the
embryo. Both procedures resulted in similar cranial neural crest
cell death and loss of frontonasal tissues. Embryos were col-
lected at the desired time, and either harvested in TRIzol (Life
Technologies, Grand Island, NY) for RNA isolation or fixed in
4% paraformaldehyde (PFA) for either cell death analysis or in
situ hybridization. Whole-mount in situ hybridizations were
performed as described (11). Whole mount HNK-1 staining was
performed by soaking fixed embryos in HNK-1 supernatant
(Development Studies Hybridoma Bank, Iowa City), followed by
overnight incubation in 1:100 goat anti-mouse IgM–AP
(Zymed), using BCIP (5-bromo-4-chloro-3-indolyl phosphate)
NBT (nitroblue tetrazolium chloride) to visualize.
Cranial Neural Crest Cell Death. Fixed embryos were cryoprotected
in sucrose, then embedded in gelatin and sectioned on a cryostat
at 10 m. Sections were briefly heated to 42°C to remove the
gelatin, then blocked in 20% heat-inactivated goat serum in a
solution of PBSBSA  0.1% Triton, with all further dilutions
also being made in this solution. The sections were incubated
overnight at 4°C in HNK-1 supernatant (1:10), followed by
anti-mouse IgM–FITC (1:500; Zymed). Finally, the sections
were incubated for 10 min in 10 gml of the nuclear marker
4,6-diamidino-2-phenylindole (DAPI) made in water, then cov-
erslips were applied. The percentage of dead cranial crest cells
was determined as described (1). All statistics were performed
using STATVIEW software.
Size Measurements. Embryos were photographed at fixed mag-
nifications, which changed at different ages and with different
head positions. The digital photographs were analyzed using the
measuring tool available in PHOTOSHOP software (Adobe Sys-
tems, Mountain View, CA).
Hybridoma Treatments. Stage 9–10 chick embryos were injected
with a function-blocking anti-Shh antibody (Development Stud-
ies Hybridoma Bank) as described (1).
RT-PCR. RNA was pooled from 4–6 embryos per experiment and
treated to remove genomic DNA, then cDNA was synthesized
using SuperscriptII. Alternatively, RNA was collected from the
heads of 6–7 embryos per condition. The relative amounts of
cDNA in each matched set was normalized for the presence of
Abbreviations: Shh, Sonic hedgehog; RT, reverse transcriptase; DAPI, 4,6-diamidino-2-
phenylindole.
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the ubiquitous gene GAPDH (12), using a Molecular Dynamics
PhosphorImager and IMAGEQUANT software (Molecular Dy-
namics). GAPDH was used as a loading control for each PCR
reaction. By the amounts of GAPDH and by visual assessment of
18S RNA, there did not appear to be a significant alteration in
the amount of RNA that was obtained from ethanol-treated
versus control embryos. The optimal cycle number for linear
amplification for each set was determined by titration using
whole-embryo cDNA from matched stages. The PCR program
used was: 94°C for 45 s, 55°C for 45 s, 72°C for 2 min. In addition
to GAPDH, the primer pairs for cPtc (13), cSmo (13), and BMP7
(14) were previously published. New primers designed for this
study were (sense primer first): cGli24, 5-GTCTATCTC-
CCCGCTGTCTG-3 and 5-CAGGATCTGCTGGTAC-
GTCA-3 (202 bp); cShh, 5-TGCTAGGATCGGTGGA-
TAG-3 and 5-ACAAGTCAGCCCAGAGGAGA-3 (197 bp);
cGli3, 5-GCAGGCTAGAGCATTTGGAC-3 and 5-CTGCT-
GACGCTTTCACCATA-3 (207 bp); and cGli1, 5-GAAAC-
CTGAACTGGAGACCA-3 and 5-GTGCACCACCAGCAT-
GTACT-3.
Viral Preparations. Concentrated virus stocks were obtained by
infecting DF-1 cells (American Type Culture Collection) with
plasmids carrying a retroviral construct capable of expressing
cShh, cFgf-8, or control constructs. The resulting supernatant
was concentrated in an ultra-centrifuge (15).
Viral Rescue Experiments. Chick embryos were incubated to the
three somite stage [HH stage 8 (16)]. They were opened after
removal of 2 ml of albumin, and a small amount of contrast agent
(dilute India Ink) was placed under the embryo. Retrovirus
encoding chick Shh was placed over the neural tube and ecto-
derm using a Picospritzer (General Valve, Fairfield, NJ). The
embryos were re-incubated for an additional 12 h, then re-
opened, and either 20 l of a 1% ethanol solution or the same
amount of Ringer’s was placed directly on the embryo surface,
below the vitelline membrane. Embryos were collected 12–14 or
20–24 h later, fixed in 4% PFA, and analyzed for cranial neural
crest cell death as described above.
Protein and Cell Rescue Experiments. Chick embryos were incu-
bated to the 8–11 somite stage (HH stage 9–10). They were
opened and exposed to ethanol as described above. Using a
Fig. 1. Ethanol treatment results ina reduction in thesizeofcraniofacial tissues.
(a and b) Embryos collected approximately 24 h after ethanol treatment (stage
9–10) show distinct differences in craniofacial growth. The measurements for the
frontonasal mass are indicated by the bar in each figure; control, 0.42 mm;
ethanol, 0.33 mm (see Table 1). (c–f ) HNK-1 whole-mount analysis of embryos1
day after ethanol treatment demonstrates a reduction in the HNK-1-positive
cranial neural crest. Streams of neural crest are indicated with arrows, and the
region around the otic vesicle (ov) is enlarged in d and e. Although crest is clearly
present inallappropriateregions, the intensityof stainingappears reduced inthe
whole-mount. HNK-1 staining of non-neural tissue, including the heart (h) ap-
pears unchanged. (f) The trunk region of ethanol-treated embryos did not
display any neural crest abnormalities when stained with HNK-1. (g) Ethanol-
treated (stage 9–10) embryos collected 3 days after treatment show distinct size
differences of the frontonasal mass (Table 1).
Fig. 2. There is increased cranial neural crest cell death after ethanol
treatment. Embryos were treated with ethanol at stage 9–10, collected 1 day
later, fixed, sectioned, and the sections stained for the neural crest marker
HNK-1 (in green) and the nuclear marker DAPI (in blue). (a and b) A section
taken from the optic cup (oc) region of a control embryo contains HNK-1-
positive neural crest cells (nc). (c and d) A section taken from the same region
of an ethanol-treated embryo also contains HNK-1-positive neural crest cells.
ec, ectoderm; di, diencephalon. (e–e). Magnified views of the area outlined
in a. A single pyknotic nucleus is present (arrow). This nucleus has an HNK-1-
positive membrane (e and e). ( f–f). Magnified views of the area outlined
in c. Arrows point to three examples of pyknotic nuclei in f, all of which have
HNK-1-positive membranes ( f). (g) Analysis of the pyknotic cells demonstrates
that exposure to ethanol resulted in a dramatic increase in the percentage of
the cranial neural crest cells (HNK-1-positive) that appear pyknotic, whereas
no change in the survival of the non-neural crest mesenchyme (HNK-1-
negative) was observed. HNK-1-positive: control n  44; ethanol n  48. *,
Unpaired t test, P  0.0001. HNK-1-negative: control n  44; ethanol n  39,
P not significant. (h) Merged image of DAPI and HNK-1 from the region
marked ‘‘h’’ in c, a region that contains almost no neural crest cells, and
demonstrates no pyknotic nuclei.














pressure-injection system we injected3 l of a 8 ngl solution
of recombinant mouse Shh amino-terminal terminal peptide
(R & D Systems) into the lateral head mesenchyme. Such
bacterially expressed recombinant Shh has been used success-
fully to activate Shh signaling by previous investigators (17, 18).
To maintain Shh protein levels for rescue of frontonasal mass
size, we performed a second injection between 12–14 h after the
first injection and collected the embryos 24 h after exposure to
ethanol. Alternatively, DF-1 cells (chicken embryo fibroblasts)
engineered to express Shh were injected into the lateral head
mesenchyme at the same time as ethanol exposure (stage 9–10),
and embryos were collected 24 h later to determine head size.
Results
There are several similarities in the craniofacial phenotypes
between embryos treated with ethanol and those treated with
antibodies that block Shh signaling. Both display reduction of the
frontonasal process, hypoplastic branchial arches, and apoptotic
death of cranial neural crest cells (Figs. 1 and 2, Table 1; refs. 1
and 6). Cranial neural crest cells are more susceptible to ethanol
treatment than are trunk neural crest cells (Fig. 1 c–f; ref. 20).
Adapting a previously established protocol as a model for fetal
alcohol syndrome in the chick (6, 7, 19), eggs were injected at
stage 9–10 with sufficient ethanol to achieve an 0.15% alcohol
level to total egg volume (20). Our results confirm that ethanol
treatment results in a loss of frontonasal mass tissue and death
of cranial neural crest cells (Figs. 1 and 2, Table 1), which are
predominantly responsible for the growth of cranial tissues
during early development (1). Measurements of the developing
eye did not reveal any reduction in eye growth at this stage (Fig.
1, Table 1). Total growth inhibition did not reach statistical
significance at early stages (i.e., 3 days post treatment; Table 1).
This finding suggests that the ethanol-induced reduction in head
size may be distinct from the general growth inhibition effects of
ethanol (21). Although a number of developmental abnormal-
ities were noted in addition to neural crest anomalies, we focused
this study on the molecular mechanisms underlying craniofacial
growth reduction and cranial neural crest cell death.
The reduction in head size and the loss of neural crest cells was
previously attributed to apoptotic death of cranial neural crest
cells (6). To confirm neural crest cell death after ethanol
exposure, we measured the percentage of pyknotic nuclei in the
Fig. 3. In situ hybridizations demonstrate changes in gene expression after ethanol exposure. In some instances, embryos were implanted with a blue agarose
bead postfixation to allow mixing during the in situ process. These can be seen in b, e, and f (white arrowheads). (a) There is no apparent change in the Wnt-1
mRNA expression 27 h after alcohol exposure (exposure at stage 10). The staining for Wnt-1 is primarily on the dorsal neural tube, but is also present in the isthmus
(i). ov, otic vesicle; h, heart. (b) Fgf-8 mRNA levels remain high 27 h after alcohol exposure (treatment at stage 10). The isthmus is stained for Fgf-8, as is the tail
bud and forebrain region (fb) at this stage. A close-up of the branchial arch region of the ethanol-treated embryos demonstrates the Fgf-8 expression is present
but reduced ventral to the otic vesicle (ov) (Inset). (c and d) Sections immediately anterior to the otic vesicle through the branchial arch demonstrate that
expression of Fgf-8 in this region. nt, neural tube; nc, notochord. (e–h) There are apparent reductions in the mRNA levels of genes in the Shh signaling pathway.
(e) Ventral view of embryos collected 24 h after ethanol treatment (at stage 9–10), with in situ hybridization for Shh. Similar results were seen for embryos
collected 27–30 h after ethanol treatment. There is a prominent reduction in head Shh (arrow). The reaction product is also decreased in the notochord (nc). ( f–h)
There is a reduction in the extent and intensity of Gli mRNA in embryos collected 25 h after ethanol treatment. (g and h) Sections through the developing eye
cup demonstrate a reduction in Gli message after ethanol treatment. Arrows point to regions demonstrating loss of Gli, compared with control sections. fb,
forebrain; h, heart; i, isthmus; nc, notochord; ov, otic vesicle; nt, neural tube.
Table 1. Frontonasal mass, eye, and body measurements respond differently to
ethanol treatment
Measurement Control, mm Ethanol-treated, mm P value
1 day embryo length 7.08  0.21 (n  13) 6.51  0.25 (n  9) 0.10
1 day FNM 0.44  0.03 (n  9) 0.30  0.04 (n  11) 0.05
1 day eye diameter 0.25  0.012 (n  14) 0.25  0.18 (n  11) 0.63
3 day embryo length 12.20  0.31 (n  13) 11.6  0.25 (n  7) 0.07
3 day FNM 0.78  0.06 (n  13) 0.53  0.07 (n  7) 0.05
3 day eye diameter 2.2  0.08 (n  13) 2.0  0.14 (n  7) 0.23
5 day FNM 1.13  0.06 (n  4) 0.81  0.07 (n  13) 0.05
5 day eye diameter 3.06  0.5 (n  4) 2.69  0.15 (n  13) 0.32
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cranial neural crest population rostral to the otic vesicle (Fig. 2).
HNK-1 immunoreactivity was used to identify cranial neural
crest cells and DAPI was used to label all of the nuclei in the
section. We found a significant enhancement of cell death in the
HNK-1-positive cranial neural crest cells after ethanol treatment
compared with control embryos (Fig. 2). In contrast, no increase
in cell death was observed in the non-neural crest regions of
cranial mesenchyme (Fig. 2 g and h).
We next examined whether exposure to alcohol altered the
expression of regulatory genes involved in craniofacial pattern-
ing. Fgf-8 and Wnt-1 are both diffusible factors that have been
implicated in cranial neural crest development. Although Wnt1
has previously been shown to be involved in the proliferation of
neural crest precursors (22), its expression appears unchanged
after exposure to ethanol (Fig. 3a). Fgf-8 is a known survival
factor for a subset of cranial neural crest cells (23). After ethanol
exposure, Fgf-8 expression appears normal in the brain and
frontonasal mass, but appears to be slightly reduced in the
branchial arches. In transverse sections, Fgf-8 expression is
present in the branchial arches (Fig. 3d). Examination of the
amount of Fgf-8 by RT-PCR in whole embryos failed to detect
a reproducible decrease in transcript levels. However, RT-PCR
analysis of isolated heads demonstrated a low, 10% loss of Fgf-8
in ethanol compared with control embryos (data not shown),
consistent with a slight reduction that may be confined to the
branchial arches.
In contrast to Wnt-1 and Fgf-8, expression of a number of
genes in the Shh signaling pathway are drastically reduced after
ethanol treatment. The expression of Shh (Fig. 3e) and Ptc
transcripts (data not shown) are markedly down-regulated after
ethanol exposure. This effect is seen primarily in the developing
head (arrow in Fig. 3e); however, Shh also appears reduced in
more posterior notochord tissues. The expression of the tran-
scription factors Gli (Fig. 3 f–h) and Gli2 (data not shown) are
also reduced by ethanol exposure.
We next examined changes in mRNA levels after ethanol
exposure by using RT-PCR (Fig. 4). RNA was collected from
embryos 24 h after treatment. The samples were normalized for
the content of GAPDH. Phosphorimaging analysis (IMAGE-
QUANT software) of matched samples demonstrates a 2–4-fold
decrease in Shh transcripts in embryos exposed to ethanol. An
even greater reduction was noted in the transcripts for Ptc (from
5–8-fold reduction) and all three Gli genes (at least 6-fold
decrease; Fig. 4 Left). Similar findings were seen when the RNA
was obtained only from the heads of the embryos (Fig. 4 Center).
In contrast, the expression of smoothened (Smo), which is also
part of the transmembrane receptor complex for Shh, was not
altered by ethanol exposure, as was true for a number of other
transcription factors and signaling molecules tested, such as
BMP-7 (Fig. 4). The effects of ethanol exposure mirror those
observed after treatment with Shh-blocking antibody, which
results in significant reduction of mRNAs of genes involved in
Shh signaling with the exception of Shh message itself (Fig. 4
Right). This finding suggests that ethanol treatment, unlike
anti-Shh antibody exposure, alters regulation of the expression
of Shh mRNA.
The results of the in situ hybridization and RT-PCR compar-
isons suggest that ethanol significantly reduces the amount of
Shh made, and thus down-regulates genes involved in Shh
signaling. Because blocking Shh signaling results in cranial
neural crest cell death (1), we tested whether addition of
exogenous Shh could rescue the neural crest cell death resulting
from ethanol exposure. To this end, Shh was overexpressed in
the head region by retrovirally mediated gene transfer. As shown
above, ethanol exposure results in significant death of cranial
neural crest cells (Fig. 5 a and a). Importantly, the ethanol-
induced cell death was completely prevented by concomitant
overexpression of Shh (Fig. 5 b–b). In control embryos, we
observed a low but significant level of cranial neural crest cell
death, as has been described (1). Although this level of cell death
might be due to limiting amounts of Shh, addition of exogenous
Shh by retroviral infection only slightly reduced the level of cell
death in controls (Fig. 5c). This finding suggests that Shh may not
be a limiting factor during normal development. As noted above,
Fgf-8 was slightly reduced by ethanol exposure. Therefore, we
used retrovirally mediated gene transfer to overexpress Fgf-8
(24) in the identical manner done for Shh. In contrast to
Shh-retrovirus, the Fgf-8 virus was unable to rescue neural crest
cell death induced by ethanol exposure (Table 2).
To control for the possible complication of secondary infec-
tion by Shh-producing retroviruses, we tested the ability of
purified Shh protein to rescue cranial neural crest cell death. We
injected approximately 50 ng of recombinant Shh into the lateral
mesenchyme on both sides of the heads of stage 9–10 embryos,
then exposed them to ethanol or control carrier. We found that
Shh protein reduced ethanol-induced cranial neural crest cell
death 12–14 h after treatment (Table 3).
In addition to causing neural crest cell death, ethanol admin-
istration resulted in significant reductions in the size of the
frontonasal mass (Fig. 1, Table 1). We examined whether the
rescue of cranial neural crest cell death by Shh was sufficient to
reverse this reduction in head growth. Because the Shh protein
degrades with time (data not shown), we treated embryos with
two doses of Shh protein with the second dose administered
12–14 h after the first, or implanted Shh-expressing cells to have
Fig. 4. Expression of certain genes is altered by exposure to ethanol. RNA
was collected from embryos one day after treatment, with Ringer’s-treated
embryos as controls. RT-PCR was used to determine the relative amounts of
the genes of interest in each set of samples. Lane 1, control whole embryo;
lane 2, ethanol whole embryo; lane 3,RT whole embryo; lane 4, control head
only; lane 5, ethanol head only; lane 6, RT head only; lane 7, control
hybridoma head only; lane 8, anti-Shh head only; lane 9,RT head only. The
enzyme GAPDH was used as a loading control, and showed no significant
variability between samples (less than 0.2-fold difference). In contrast, a
number of genes were examined that did show significant decreases in
embryos exposed to ethanol (Left). The fold differences in these examples
were (control over experimental): GADPH, 1.2 (no difference); Shh, 4
decrease; Smo, 0.9 (no difference); Ptc, 6.8 decrease; Gli1, 100 decrease;
Gli24, 6 decrease; Gli3, 5.8 decrease; BMP7, 1.0 (no difference). The fold
differences when the samples were limited to head RNA were (control over
experimental): GADPH, 1.0 (no difference); Shh, 2.5 decrease; Smo, 1.2
(no difference); Ptc, 5 decrease; Gli1, 100 decrease; Gli24, 7.5 decrease;
Gli3, 6 decrease; BMP7, 1.0 (no difference). This pattern of changes was
also seen in embryos where Shh was directly inhibited using anti-Shh hybrid-
oma cells (Right). The fold differences in these examples were (control over
experimental): GADPH, 0.8 (no difference); Shh, 1.3 (no difference); Smo,
1.0 (no difference); Ptc, 14.5 decrease; Gli1, 38 decrease; Gli24, 10.6
decrease; Gli3, 6.5 decrease.














continuous presence of protein; both methods yielded similar
results. Such continuous administration of Shh resulted in
frontonasal size that was not significantly different from control
embryos (Fig. 5 d and e). Embryos exposed to excess Shh in the
absence of ethanol demonstrated a distinct set of abnormalities
(data not shown), as has been reported (18). Thus, the combi-
nation of Shh and ethanol exposure prevents or reverses the
craniofacial growth defect observed in the embryos exposed to
ethanol alone.
Discussion
The data presented here demonstrate a link between loss of Shh
signaling and the craniofacial growth defects resulting from fetal
alcohol exposure. Ethanol exposure causes a marked down-
regulation of Shh and other molecular components of the Shh
signaling pathway, Patched, Gli, Gli2, and Gli3, with no detected
change in the levels of other signaling molecules like Wnt1 or
BMP7 and only minor effects on Fgf-8. The specificity of the
effect is confirmed by the rescue of the cranial neural crest cell
death and size of the frontonasal mass by administration of Shh,
but not Fgf-8. Embryos treated with antibodies to Shh demon-
strate a similar down-regulation of Shh signaling components
and also have similar craniofacial phenotypes.
In a previous study in zebrafish, exposure to ethanol were
reported to down-regulate Shh levels (25). However, the doses
used were sufficiently high to cause failure of prechordal
mesoderm to migrate anteriorly. This alone can lead to loss of
cranial Shh. Therefore, the apparent down-regulation may have
been secondary to mesodermal defects. In the present study, we
see significant effects on Shh message and cranial neural crest
survival even in embryos treated at stage 10, well after pre-
chordal mesoderm migration has occurred. In addition, we do
not see any sign of cyclopia in our embryos, which would indicate
a loss of prechordal mesoderm. Finally, the levels of BMP7,
another marker of prechordal mesoderm (26), appears un-
changed. Therefore, we conclude that our effects are not due to
loss of prechordal mesoderm.
Although we do not know whether the actions of Shh on
cranial neural crest cells are direct or indirect, we previously
showed that cranial neural crest cells migrating toward the
branchial arches express the Ptc receptor (1), as well as
the transcription factor Gli2 (data not shown), consistent with
the possibility that they directly respond to Shh. Additional
evidence for a direct effect of Shh on cranial neural crest cells
comes from studies that drive excess Ptc by using a first arch
neural crest specific promoter, and in which a decrease in the size
of the first arch was noted, suggesting the size difference is due
to a direct effect of Shh on cranial neural crest (27). It is
interesting to note that the presence of excess Shh protein does
not reduce the cell death in the cranial neural crest, and does not
appear to be a limiting survival factor. Trunk neural crest cells
in culture, although not requiring Shh for survival or prolifera-
tion, respond to Shh by altering their migratory behavior, and do
so independently of the canonical Shh signaling pathway (28).
Shh may represents a pivotal ‘‘checkpoint’’ in craniofacial
development on which many environmental and growth fac-
tors act. For example, the reduction of Shh shown here is
reminiscent of that seen when retinoid levels are perturbed
(29), consistent with the suggestion that one action of ethanol
during development is to perturb retinoic acid levels (30, 31).
Perturbing retinoic acid appears to affect both Shh and Fgf-8
genes equally and rescue requires expression of both genes
(29), unlike the effects seen with ethanol treatment. The
Fig. 5. Sonic hedgehog rescues cranial neural crest cell death and fronto-
nasal growth defects resulting from ethanol exposure. (a and b) Representa-
tive sections through the frontonasal cranial mesenchyme, stained with DAPI
(a and b) to show nuclear phenotype or with HNK-1 (a and b) to stain neural
crest cells; aand b show merged images. (a) DAPI staining reveals numerous
pyknotic nuclei (arrows) in the cranial mesenchyme of embryos exposed to
ethanol when infected with a control retrovirus. (aand a) These cells express
the neural crest marker HNK-1. (b–b) Few pyknotic nuclei are seen in the
cranial mesenchyme of embryos that are infected with a retrovirus that
expresses cShh and exposed to ethanol, including cells that express the neural
crest marker HNK-1. (c) Analysis of the cranial mesenchyme demonstrates that
exposure to ethanol resulted in a dramatic increase in the percentage of the
cranial neural crest cells that were pyknotic (first bar), an effect that is
completely lost when the embryo is treated with a virus expressing cShh
(second bar). The cranial neural crest cell death in embryos that were infected
with cShh containing virus but not exposed to alcohol was not different from
that seen under control conditions (third and fourth bars). The number of
sections analyzed is noted above each bar. (d and e) Shh overexpression
rescues the frontonasal growth defect induced by ethanol. (d) embryos
treated with Shh were fixed and examined as for Table 1. The number of
embryos examined is noted above each bar. The asterisk indicates that ethanol
causes a significant decrease in frontonasal mass (P 0.01), which is no longer
true when Shh is present. (e) examples of embryos treated with ethanol and
BSA (Left) or Shh (Right).
Table 2. Fgf-8 viral overexpression does not reduce the
percentage of apoptotic cranial neural crest cell death after
ethanol treatment
Control, % Ethanol, % P value
Control virus 4.0  1.0 (n  42) 11.1  2.5 (n  23) 0.003
Fgf-8 virus 2.5  0.5 (n  40) 9.6  1.7 (n  46) 0.003
Table 3. Shh protein reduces the percentage of cranial neural
crest cells that are apoptotic after ethanol treatment
Control, % Ethanol, % P value
No protein 12 h 3.0  0.54 (n  45) 16.2  2.4 (n  38) 0.0001
BSA 12 h 3.1  0.54 (n  47) 10.27  1.8 (n  43) 0.0002
SHH 12 h 3.67  0.72 (n  52) 2.20  0.42 (n  48) n.s.
n.s., not significant.
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relationship between the molecular changes demonstrated
here and those seen when retinoid signaling is perturbed need
to be further studied. Fetal exposure to alcohol can now be
added to the list of environmental insults that result in
craniofacial birth defects via an interruption of Shh signaling
or message levels. Other such environmental insults include
retinoic acid exposure (29), cholesterol biosynthesis inhibition
(32), and some plant teratogens (27, 33). Taken together, these
data establish a firm link between fetal alcohol syndrome and
decreased Shh signaling, leading to subsequent cranial neural
crest cell death, and thus reinforcing the importance of Shh in
craniofacial development.
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